Antibody Response to Influenza Hemagglutinin Conserved Stalk Domain after Sequential Immunization with Old Vaccine Strains

Antibody Response to Influenza Hemagglutinin Conserved Stalk Domain after Sequential Immunization with Old Vaccine Strains

Hemagglutinin (HA) is the major envelope glycoprotein and antigen on the surface of influenza virions. The glycoprotein comprises a globular head and a stalk region. While immunodominant epitopes on influenza HA head are highly variable, the stalk domain is conserved. The variability of the HA head...

Full description

Bibliographic Details
Main Authors:	Alita Kongchanagul, Promsin Masrinoul, Chompunuch Boonarkart, Ornpreya Suptawiwat, Prasert Auewarakul
Format:	Article
Language:	English
Published:	Hindawi Limited 2024-01-01
Series:	Advances in Virology
Online Access:	http://dx.doi.org/10.1155/2024/5691673

Similar Items

Human Schlafen 11 inhibits influenza A virus production
by: Kunlakanya Jitobaom, et al.
Published: (2023-09-01)

Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition
by: Nattamon Niyomdecha, et al.
Published: (2020-06-01)

Enhanced susceptibility of nasal polyp tissues to avian and human influenza viruses.
by: Ornpreya Suptawiwat, et al.
Published: (2010-01-01)

Microparticle and anti-influenza activity in human respiratory secretion.
by: Ornpreya Suptawiwat, et al.
Published: (2017-01-01)

Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
by: John Steel, et al.
Published: (2010-05-01)

A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
by: Jutatip Panaampon, et al.
Published: (2012-01-01)

An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains
by: Weina Sun, et al.
Published: (2019-09-01)

In silico and in vitro studies of potential inhibitors against Dengue viral protein NS5 Methyl Transferase from Ginseng and Notoginseng
by: Viwan Jarerattanachat, et al.
Published: (2023-01-01)

Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies.
by: Peter H Goff, et al.
Published: (2013-01-01)

Codon usage similarity between viral and some host genes suggests a codon-specific translational regulation
by: Kunlakanya Jitobaom, et al.
Published: (2020-05-01)

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans
by: Raffael Nachbagauer, et al.
Published: (2016-03-01)

Apoptosis and Pathogenesis of Avian Influenza A (H5N1) Virus in Humans
by: Mongkol Uiprasertkul, et al.
Published: (2007-05-01)

Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration.
by: Arkom Nongnuch, et al.
Published: (2020-01-01)

An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice
by: Eun Hye Kim, et al.
Published: (2017-08-01)

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
by: Kunlakanya Jitobaom, et al.
Published: (2022-06-01)

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
by: Sabari Nath Neerukonda, et al.
Published: (2020-07-01)

Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus
by: Jingjin Huang, et al.
Published: (2020-12-01)

A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates.
by: Florian Krammer, et al.
Published: (2012-01-01)

Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
by: Titus Abiola Olukitibi, et al.
Published: (2022-08-01)

Group 1 and group 2 hemagglutinin stalk antibody response according to age
by: Laura Sánchez-de Prada, et al.
Published: (2023-05-01)

Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
by: Miriam Klausberger, et al.
Published: (2016-01-01)

Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV
by: Boitumelo M. Motsoeneng, et al.
Published: (2022-04-01)

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies
by: Juan Manuel Carreño, et al.
Published: (2020-11-01)

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin
by: Walter Ramage, et al.
Published: (2019-02-01)

Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses
by: Chenchen Jiao, et al.
Published: (2023-02-01)

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
by: Taia T Wang, et al.
Published: (2010-02-01)

The Hemagglutinin-Neuraminidase (HN) Head Domain and the Fusion (F) Protein Stalk Domain of the Parainfluenza Viruses Affect the Specificity of the HN-F Interaction
by: Masato Tsurudome, et al.
Published: (2018-03-01)

Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies
by: Clara J. Sei, et al.
Published: (2021-06-01)

Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes.
by: Dustin M McCraw, et al.
Published: (2023-08-01)

Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks
by: Andrew M. Wollacott, et al.
Published: (2016-03-01)

T cell mediated immunity against influenza H5N1 nucleoprotein, matrix and hemagglutinin derived epitopes in H5N1 survivors and non-H5N1 subjects
by: Pirom Noisumdaeng, et al.
Published: (2021-03-01)

Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus
by: Jae-Keun Park, et al.
Published: (2018-03-01)

Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails
by: B Farahmand, et al.
Published: (2017-05-01)

Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex
by: Lin Chi-Hui, et al.
Published: (2008-01-01)

Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin.
by: Ki Joon Cho, et al.
Published: (2014-01-01)

The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.
by: Simon E Hufton, et al.
Published: (2014-01-01)

Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner
by: Caitlin E. Mullarkey, et al.
Published: (2016-11-01)

Production of polyclonal antibody against Tehran strain influenza virus (A/H1N1/2009) hemagglutinin conserved domain (HA2): brief report
by: Somayeh Zamani, et al.
Published: (2015-10-01)

Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains.
by: Hannah L Turner, et al.
Published: (2019-02-01)

MONOCLONAL ANTIBODIES TO HEMAGGLUTININ OF INFLUENZA B VIRUSES VICTORIA EVOLUTIONARY LINEAGE
by: E. V. Sorokin, et al.
Published: (2018-12-01)